Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208


Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.

Parker PA, Peterson SK, Bedrosian I, Crosby MA, Shen Y, Black DM, Babiera G, Kuerer HM, Ying J, Dong W, Cantor SB, Brewster AM.

Ann Surg. 2016 Jan;263(1):178-83. doi: 10.1097/SLA.0000000000001216.


Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.

Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M, Winer EP, Partridge AH.

Ann Surg Oncol. 2015 Nov;22(12):3809-15. doi: 10.1245/s10434-015-4572-6. Epub 2015 May 1.


Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.

Brewster AM, Parker PA.

Oncologist. 2011;16(7):935-41. doi: 10.1634/theoncologist.2011-0022. Epub 2011 Jun 14. Review.


Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.

Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ.

JAMA Surg. 2014 Jun;149(6):582-9. doi: 10.1001/jamasurg.2013.5689.


Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer.

Soran A, Ibrahim A, Kanbour M, McGuire K, Balci FL, Polat AK, Thomas C, Bonaventura M, Ahrendt G, Johnson R.

Am J Clin Oncol. 2015 Apr;38(2):179-83. doi: 10.1097/COC.0b013e318292f8a7.


Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?

Tesson S, Richards I, Porter D, Phillips KA, Rankin N, Costa D, Musiello T, Marven M, Butow P.

Breast. 2017 Feb;31:233-240. doi: 10.1016/j.breast.2016.11.025. Epub 2016 Dec 13.


Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.

Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH.

Ann Intern Med. 2013 Sep 17;159(6):373-81. doi: 10.7326/0003-4819-159-6-201309170-00003.


Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.

Grimmer L, Liederbach E, Velasco J, Pesce C, Wang CH, Yao K.

J Am Coll Surg. 2015 Jul;221(1):187-96. doi: 10.1016/j.jamcollsurg.2015.03.033. Epub 2015 Apr 23.


Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.

Hamilton JG, Genoff MC, Salerno M, Amoroso K, Boyar SR, Sheehan M, Fleischut MH, Siegel B, Arnold AG, Salo-Mullen EE, Hay JL, Offit K, Robson ME.

Breast Cancer Res Treat. 2017 Apr;162(2):297-306. doi: 10.1007/s10549-017-4123-x. Epub 2017 Feb 1.


The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.

Hawley ST, Griffith KA, Hamilton AS, Ward KC, Morrow M, Janz NK, Katz SJ, Jagsi R.

Cancer. 2017 Dec 1;123(23):4547-4555. doi: 10.1002/cncr.30924. Epub 2017 Aug 15.


'Taking control of cancer': understanding women's choice for mastectomy.

Covelli AM, Baxter NN, Fitch MI, McCready DR, Wright FC.

Ann Surg Oncol. 2015 Feb;22(2):383-91. doi: 10.1245/s10434-014-4033-7. Epub 2014 Sep 5.


Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.

Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F.

Cancer Prev Res (Phila). 2010 Aug;3(8):1026-34. doi: 10.1158/1940-6207.CAPR-09-0130. Epub 2010 Jul 20.


Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.

Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM.

J Clin Oncol. 2018 Sep 1;36(25):2630-2638. doi: 10.1200/JCO.2018.78.6442. Epub 2018 Jul 25.


Women's decision-making roles regarding contralateral prophylactic mastectomy.

Nekhlyudov L, Bower M, Herrinton LJ, Altschuler A, Greene SM, Rolnick S, Elmore JG, Harris EL, Liu A, Emmons KM, Fletcher SW, Geiger AM.

J Natl Cancer Inst Monogr. 2005;(35):55-60.


Contralateral prophylactic mastectomy for patients with unilateral breast cancer.

Tuttle T, Habermann E, Abraham A, Emory T, Virnig B.

Expert Rev Anticancer Ther. 2007 Aug;7(8):1117-22. Review.


Should the use of contralateral prophylactic mastectomy be increasing as it is?

Wood WC.

Breast. 2009 Oct;18 Suppl 3:S93-5. doi: 10.1016/S0960-9776(09)70282-6.


Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.

Musiello T, Bornhammar E, Saunders C.

ANZ J Surg. 2013 Jul;83(7-8):527-32. doi: 10.1111/j.1445-2197.2012.06209.x. Epub 2012 Oct 8.


Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.

Ager B, Jansen J, Porter D, Phillips KA, Glassey R; CPM DA Advisory Group, Butow P.

Breast. 2018 Aug;40:156-164. doi: 10.1016/j.breast.2018.05.009. Epub 2018 May 22.


Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.

Richards I, Tesson S, Porter D, Phillips KA, Rankin N, Musiello T, Marven M, Butow P.

Eur J Oncol Nurs. 2016 Apr;21:57-65. doi: 10.1016/j.ejon.2015.12.002. Epub 2016 Feb 2.


Contralateral prophylactic mastectomy in an Asian population: a single institution review.

Sim Y, Tan VK, Ho GH, Wong CY, Madhukumar P, Tan BK, Yong WS, Ng YY, Ong KW.

Breast. 2014 Feb;23(1):56-62. doi: 10.1016/j.breast.2013.10.008. Epub 2013 Nov 23.


Supplemental Content

Support Center